Revista Espanola de Quimioterapia

Papers
(The H4-Index of Revista Espanola de Quimioterapia is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Cefiderocol64
48
Evaluation of two immunocromatographic tests for the detection of antibodies against SARS-CoV-245
COVID-19: Impact on prescribing and antimicrobial resistance45
32
COVID-19 in donation and transplant30
Mechanical ventilation associated pneumonia during ECMO therapy. A challenge for the Intensive Care physician20
Prevalence of SARS-CoV-2 infection during the first wave of the pandemic among health and non-health personnel of the General Hospital of Segovia, Castilla y León20
Invasive group A Streptococcus infection (Streptococcus pyogenes): Current situation in Spain16
Systemic absorption of liposomal inhaled amikacin in the treatment of resistant Mycobacterium avium: beyond expectations15
Application of CMO (capacity, motivation, and opportunity) methodology in pharmaceutical care to optimize the pharmacotherapy in older people living with HIV. DISPIMDINAC project15
Usefulness of monocyte distribution width (MDW) as a sepsis biomarker15
Is Propionimicrobium lymphophilum a new urinary tract infection cause?14
Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences14
0.030818939208984